BODI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Beachbody Company Inc (BODI) is not a strong buy at this time for a beginner investor focused on long-term growth. The company's financial performance is weak, with significant revenue and net income declines, and there are no immediate positive catalysts or strong trading signals to justify an entry. Analysts are optimistic about the company's turnaround efforts, but the lack of recent news, neutral insider and hedge fund activity, and poor technical indicators suggest waiting for clearer signs of recovery before investing.
The technical indicators for BODI are neutral to bearish. The MACD is below zero and negatively contracting, RSI is neutral at 52.437, and moving averages are converging. The stock is trading near its support level (S1: 9.818), with resistance levels at R1: 11.827 and R2: 12.448. There is no clear upward momentum.
Analysts have raised price targets recently, citing the company's turnaround efforts and new product launches like Shakeology, P90X, and Insanity entering retail for the first time. Gross margin has improved YoY to 74.45%.
The company's financial performance in Q4 2025 was weak, with revenue dropping 35.70% YoY and net income declining by 115.10% YoY. EPS also fell significantly by 114.68% YoY. There is no recent news, and insider and hedge fund activity are neutral.
In Q4 2025, Beachbody's revenue dropped to $55.54M (-35.70% YoY), net income dropped to $5.22M (-115.10% YoY), and EPS fell to 0.74 (-114.68% YoY). However, gross margin increased to 74.45% (+5.63% YoY).
Analysts are optimistic, with recent upgrades in price targets from Canaccord ($15 from $12) and Craig-Hallum initiating coverage with a Buy rating and a $15 price target. Analysts highlight the company's turnaround efforts and new growth opportunities but acknowledge past challenges with MLM and SPAC-related issues.
